Evaluation of Preoperative N1539 in Colorectal Surgery
Status:
Completed
Trial end date:
2018-09-26
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of
preoperative dosing of N1539 30 mg in subjects undergoing colorectal surgery, including
clinical laboratory tests, wound healing evaluation, incidence of anastomotic leaks, and
incidence of Adverse Events (AEs) and Serious AEs (SAEs).